Cardiac biomarkers levels predict pulmonary embolism extent on chest computed tomography and prognosis in non-massive pulmonary embolism

Autor: F. Verschuren, Nicolas Vuilleumier, Damien Gruson, Noury Mensi, Marc Philip Righini, Arnaud Perrier, Grégoire Le Gal, Natacha Turck, Jean-Charles Sanchez, Denis F. Hochstrasser
Přispěvatelé: Calvez, Ghislaine, Department of Pathology, Clinical Chemistry (NV - DPCC), Geneva University Hospital (HUG), Service de médecine interne générale (SMIG), Hôpital Universitaire de Genève, Biomedical Proteomics Research Group (BPRG), Centre médical universitaire, Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), Centre d'Investigation Clinique (CIC - Brest), Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire de Protéomique Clinique, Service de Médecine de Laboratoire, HCUG, Service d'angiologie et d'hémostase (MR)
Rok vydání: 2009
Předmět:
MESH: Pulmonary Embolism
Male
Computed tomography
030204 cardiovascular system & hematology
Chest pain
MESH: Aged
80 and over

0302 clinical medicine
X ray computed
030212 general & internal medicine
ComputingMilieux_MISCELLANEOUS
MESH: Treatment Outcome
ddc:616
MESH: Aged
Aged
80 and over

Venous Thrombosis
MESH: Middle Aged
[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology
medicine.diagnostic_test
MESH: Chest Pain
Follow up studies
MESH: Follow-Up Studies
Hematology
Middle Aged
Prognosis
Thrombosis
3. Good health
Pulmonary embolism
Treatment Outcome
MESH: Dyspnea
Disease Progression
MESH: Disease Progression
Female
Radiology
medicine.symptom
MESH: Tomography
X-Ray Computed

MESH: Hemorrhage
Adult
medicine.medical_specialty
Chest Pain
MESH: Myocardium
Cardiac biomarkers
Hemorrhage
MESH: Anticoagulants
MESH: Prognosis
03 medical and health sciences
medicine
Humans
ddc:576
Aged
MESH: Humans
business.industry
Myocardium
Disease progression
MESH: Biological Markers
Anticoagulants
MESH: Adult
medicine.disease
MESH: Male
Dyspnea
MESH: Venous Thrombosis
business
Pulmonary Embolism
Tomography
X-Ray Computed

MESH: Female
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Biomarkers
Follow-Up Studies
Zdroj: Thrombosis and Haemostasis
Thrombosis and Haemostasis, Schattauer, 2009, 101 (6), pp.1176-8
Thrombosis and Haemostasis, Vol. 101, No 6 (2009) pp. 1176-8
ISSN: 0340-6245
Popis: Cardiac biomarkers levels predict pulmonary embolism extent on chest computed tomography and prognosis in non-massive pulmonary embolism
Databáze: OpenAIRE